2021 Q1 Form 10-Q Financial Statement

#000127547721000002 Filed on May 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q1
Revenue $3.142M $3.353M $4.129M
YoY Change -23.91% -28.2% -0.8%
Cost Of Revenue $289.4K $300.5K $1.277M
YoY Change -77.34% -77.31% -25.71%
Gross Profit $3.511M $3.053M -$13.23M
YoY Change -126.55% -8.75% -447.84%
Gross Profit Margin 111.74% 91.04% -320.27%
Selling, General & Admin $1.757M $1.660M $1.706M
YoY Change 2.97% 2.84% 5.24%
% of Gross Profit 50.03% 54.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $17.31K $17.32K $17.60K
YoY Change -1.62% -4.68% -4.62%
% of Gross Profit 0.49% 0.57%
Operating Expenses $1.756M $1.660M $1.706M
YoY Change 2.93% 2.84% 5.24%
Operating Profit $1.755M $1.393M -$14.93M
YoY Change -111.75% -19.56% -784.57%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $658.4K -$16.08M
YoY Change -104.1% -1283.04%
Pretax Income $1.755M $1.393M -$14.93M
YoY Change -111.75% -19.56% -784.57%
Income Tax $500.0K -$10.67M $7.400M
% Of Pretax Income 28.49% -765.84%
Net Earnings $1.290M $12.06M -$22.33M
YoY Change -105.78% -6.93% -1479.77%
Net Earnings / Revenue 41.07% 359.59% -540.83%
Basic Earnings Per Share
Diluted Earnings Per Share $110.9K $1.036M -$1.919M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.973M $7.558M $5.871M
YoY Change 1.74% -6.34% 17.34%
Cash & Equivalents $5.973M $7.558M $5.871M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $212.1K $202.2K $223.3K
Other Receivables $711.7K $632.5K $0.00
Total Short-Term Assets $6.897M $8.393M $6.094M
YoY Change 13.17% -4.85% 5.66%
LONG-TERM ASSETS
Property, Plant & Equipment $2.076M $2.093M $2.145M
YoY Change -3.23% -3.24% -34.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $72.86M $65.18M $54.44M
YoY Change 33.82% -70.08% -74.28%
Other Assets $38.24M $38.02M $27.20M
YoY Change 40.59% -0.08% 12.27%
Total Long-Term Assets $130.3M $120.3M $92.02M
YoY Change 41.64% -55.55% -63.63%
TOTAL ASSETS
Total Short-Term Assets $6.897M $8.393M $6.094M
Total Long-Term Assets $130.3M $120.3M $92.02M
Total Assets $137.2M $128.7M $98.11M
YoY Change 39.88% -53.95% -62.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $91.84K $107.4K $109.6K
YoY Change -16.18% -83.35% -74.8%
Deferred Revenue
YoY Change
Short-Term Debt $73.14M $65.07M $52.36M
YoY Change 39.69% -69.01% -73.71%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $73.23M $65.18M $52.47M
YoY Change 39.57% -69.05% -73.71%
LONG-TERM LIABILITIES
Long-Term Debt $27.61M $27.61M $27.48M
YoY Change 0.48% 0.48% 2.51%
Other Long-Term Liabilities $619.6K $1.421M $523.9K
YoY Change 18.27% -0.71% -71.47%
Total Long-Term Liabilities $28.23M $29.03M $28.00M
YoY Change 0.81% 0.42% -2.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $73.23M $65.18M $52.47M
Total Long-Term Liabilities $28.23M $29.03M $28.00M
Total Liabilities $101.5M $94.21M $80.47M
YoY Change 26.08% -60.66% -64.74%
SHAREHOLDERS EQUITY
Retained Earnings -$298.2M -$315.0M
YoY Change 1.88% 3.5%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.78M $34.49M $17.60M
YoY Change
Total Liabilities & Shareholders Equity $137.2M $128.7M $98.11M
YoY Change 39.88% -53.95% -62.09%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q1
OPERATING ACTIVITIES
Net Income $1.290M $12.06M -$22.33M
YoY Change -105.78% -6.93% -1479.77%
Depreciation, Depletion And Amortization $17.31K $17.32K $17.60K
YoY Change -1.62% -4.68% -4.62%
Cash From Operating Activities $109.9K $1.145M -$3.568M
YoY Change -103.08% -43.52% 160.26%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$9.070M $8.296M $155.5M
YoY Change -105.83% -115.17% 4807.87%
Cash From Investing Activities -$9.070M $8.296M $155.5M
YoY Change -105.83% -115.17% 4807.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $5.420K $5.077K
YoY Change 6.76%
Cash From Financing Activities $8.059M -5.619M -$157.6M
YoY Change -105.11% -110.01% 12492.62%
NET CHANGE
Cash From Operating Activities $109.9K 1.145M -$3.568M
Cash From Investing Activities -$9.070M 8.296M $155.5M
Cash From Financing Activities $8.059M -5.619M -$157.6M
Net Change In Cash -$900.5K 3.821M -$5.650M
YoY Change -84.06% 9.36% -1134.47%
FREE CASH FLOW
Cash From Operating Activities $109.9K $1.145M -$3.568M
Capital Expenditures $0.00
Free Cash Flow $109.9K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
610618 USD
CY2021Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
11673 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
11673 USD
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001275477
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-32171
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Bimini Capital Management, Inc.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
72-1571637
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3305 Flamingo Drive
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Vero Beach
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32963
CY2021Q1 dei City Area Code
CityAreaCode
772
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
231-1400
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 us-gaap Financial Instruments Owned And Pledged As Collateral At Fair Value
FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue
72833006 USD
CY2020Q4 us-gaap Financial Instruments Owned And Pledged As Collateral At Fair Value
FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue
65153274 USD
CY2021Q1 us-gaap Financial Instruments Owned And Not Pledged At Fair Value
FinancialInstrumentsOwnedAndNotPledgedAtFairValue
22826 USD
CY2020Q4 us-gaap Financial Instruments Owned And Not Pledged At Fair Value
FinancialInstrumentsOwnedAndNotPledgedAtFairValue
24957 USD
CY2021Q1 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
72855832 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4037655 USD
CY2021Q1 us-gaap Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
15598096 USD
CY2020Q4 us-gaap Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
13547764 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
202192 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2076127 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2093440 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
34204364 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
34668467 USD
CY2021Q1 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
711657 USD
CY2020Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
632471 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1564005 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1466647 USD
CY2021Q1 us-gaap Assets
Assets
137233034 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
1421409 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
107417 USD
CY2021Q1 us-gaap Revenues
Revenues
3142122 USD
CY2021Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
73135999 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
65071113 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27607361 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27612781 USD
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
91841 USD
CY2021Q1 us-gaap Liabilities
Liabilities
101454755 USD
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
332642758 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-298166582 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
35778279 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
137233034 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2025409 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1724597 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2039994 USD
CY2021Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
506095 USD
CY2020Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
364809 USD
CY2020Q1 us-gaap Revenues
Revenues
4129400 USD
CY2020Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
927816 USD
CY2020Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
349501 USD
CY2021Q1 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
2852716 USD
CY2020Q1 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
2852083 USD
CY2020Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-574281 USD
CY2020Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-5804656 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2050332 USD
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4408105 USD
CY2021Q1 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
243 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
324 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16077449 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1100044 USD
CY2020Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
164581 USD
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
159293 USD
CY2020Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
282039 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1705957 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1754533 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14931323 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
464103 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7401624 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1290430 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-22332947 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-22332947 USD
CY2021Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
39858 USD
CY2021Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
249548 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
155519616 USD
CY2020Q1 bmnm Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
361393397 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17644044 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34487849 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35778279 USD
CY2021Q1 bmnm Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
66734114 USD
CY2020Q1 bmnm Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
518990000 USD
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
5420 USD
CY2020Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
5077 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8059466 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-157601680 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-900455 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5650359 USD
CY2020Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-1441406 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
9859 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-527542 USD
CY2021Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
79186 USD
CY2020Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-101800 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
97358 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-15576 USD
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-535734 USD
CY2021Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-801855 USD
CY2020Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-849083 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
109941 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3568295 USD
CY2021Q1 bmnm Payments To Acquire Mortgage Backed Securities Mbs Categorized As Trading
PaymentsToAcquireMortgageBackedSecuritiesMbsCategorizedAsTrading
12367589 USD
CY2020Q1 bmnm Payments To Acquire Mortgage Backed Securities Mbs Categorized As Trading
PaymentsToAcquireMortgageBackedSecuritiesMbsCategorizedAsTrading
20823373 USD
CY2021Q1 bmnm Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
0 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
1290430 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-22332947 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17313 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17598 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
464103 USD
CY2020Q1 bmnm Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
171155249 USD
CY2021Q1 bmnm Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading
3297727 USD
CY2021Q1 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
0 USD
CY2020Q1 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
1500000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9069862 USD
CY2021Q1 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-1392261 USD
CY2020Q1 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-6378937 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2050332 USD
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4408105 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
0 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10911357 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12385117 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10010902 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6734758 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
304982 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
1813051 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13465 USD
CY2021Q1 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
72856000 USD
CY2021Q1 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
0 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div id="TextBlockContainer13" style="position:relative;font-family:Arial;font-size:14.72px;font-stretch:condensed;color:#000000;line-height:normal;width:726px;height:153px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2345" style="position:absolute;font-weight:bold;font-style:normal;left:4.475px;top:0px;">Use of Estimates </div><div id="a2347" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:19.4px;"> </div><div id="a2348" style="position:absolute;font-weight:normal;font-style:normal;left:28.475px;top:38.8px;">The preparation of financial statements in conformity with GAAP requires management<div style="display:inline-block;width:1.84px"> </div>to make estimates and assumptions that </div><div id="a2350" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:58.2px;">affect the reported amounts of assets and liabilities and disclosure of contingent assets and<div style="display:inline-block;width:1.77px"> </div>liabilities at the date of the consolidated </div><div id="a2352" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:77.5px;">financial statements and the reported amounts of revenues and expenses during<div style="display:inline-block;width:2px"> </div>the reporting period. Actual results could differ from </div><div id="a2354" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:96.9px;">those estimates.<div style="display:inline-block;width:6.49px"> </div>Significant estimates affecting the accompanying consolidated financial statements include<div style="display:inline-block;width:1.95px"> </div>determining the fair </div><div id="a2356" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:116.2px;">values of MBS, investment in Orchid common shares and derivatives, determining<div style="display:inline-block;width:1.87px"> </div>the amounts of asset valuation allowances, and the </div><div id="a2358" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:135.6px;">computation of the income tax provision or benefit and the deferred tax asset allowances<div style="display:inline-block;width:1.92px"> </div>recorded for each accounting period.</div></div>
CY2020Q1 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-5291000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5973247 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7558342 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4037655 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3353015 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10010902 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10911357 USD
CY2021Q1 bmnm Advisory Services Other Segments
AdvisoryServicesOtherSegments
0 USD
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1117000 USD
CY2021Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
290000 USD
CY2021Q1 bmnm Net Segment Revenue
NetSegmentRevenue
2852000 USD
CY2021Q1 us-gaap Other Income
OtherIncome
659000 USD
CY2021Q1 bmnm Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
73136000 USD
CY2021Q1 bmnm Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
0 USD
CY2021Q1 bmnm Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
73136000 USD
CY2021Q1 bmnm Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
-69099000 USD
CY2021Q1 bmnm Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
-4037000 USD
CY2021Q1 bmnm Net Amount Of Liabilities
NetAmountOfLiabilities
0 USD
CY2020Q4 bmnm Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
65071000 USD
CY2020Q4 bmnm Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
0 USD
CY2020Q4 bmnm Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
65071000 USD
CY2020Q4 bmnm Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
-61719000 USD
CY2020Q4 bmnm Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
-3352000 USD
CY2020Q4 bmnm Net Amount Of Liabilities
NetAmountOfLiabilities
0 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27607000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27613000 USD
CY2021Q1 bmnm Scheduled Principal Payments
ScheduledPrincipalPayments
27455000 USD
CY2021Q1 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
72856000 USD
CY2021Q1 us-gaap Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
15598000 USD
CY2020Q4 us-gaap Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
13548000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2025000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7400000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1800000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14900000 USD
CY2020Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11200000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1286000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
1756000 USD
CY2021Q1 bmnm Intercompany Expenses
IntercompanyExpenses
0 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1755000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1725000 USD
CY2020Q1 bmnm Advisory Services Other Segments
AdvisoryServicesOtherSegments
0 USD
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2405000 USD
CY2020Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1278000 USD
CY2020Q1 bmnm Net Segment Revenue
NetSegmentRevenue
2852000 USD
CY2020Q1 us-gaap Other Income
OtherIncome
-16077000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
1706000 USD
CY2020Q1 bmnm Intercompany Expenses
IntercompanyExpenses
0 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14931000 USD
CY2021Q1 us-gaap Assets
Assets
137233000 USD
CY2020Q4 us-gaap Assets
Assets
128701000 USD

Files In Submission

Name View Source Status
0001275477-21-000002-index-headers.html Edgar Link pending
0001275477-21-000002-index.html Edgar Link pending
0001275477-21-000002.txt Edgar Link pending
0001275477-21-000002-xbrl.zip Edgar Link pending
bmnm-20210331.xsd Edgar Link pending
bmnm-20210331_cal.xml Edgar Link unprocessable
bmnm-20210331_def.xml Edgar Link unprocessable
bmnm-20210331_lab.xml Edgar Link unprocessable
bmnm-20210331_pre.xml Edgar Link unprocessable
bmnm10q20210331.htm Edgar Link pending
bmnm10q20210331.pdf Edgar Link pending
bmnm10q20210331p1i0.jpg Edgar Link pending
bmnm10q20210331x311.htm Edgar Link pending
bmnm10q20210331x312.htm Edgar Link pending
bmnm10q20210331x321.htm Edgar Link pending
bmnm10q20210331x322.htm Edgar Link pending
bmnm10q20210331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending